Professor Emeritus of Pathology Jeffrey Everitt, DVM, DACVP, FIATP, was appointed to the National Institutes of Health (NIH) Board of Scientific Counselors, Division of Translational Toxicology (DTT), National Institute of Environmental Health Sciences for the term beginning July 01, 2024 and ending on June 30, 2028. The DTT main charge is to support the National Toxicology Program. As part of the recently created board, Everitt will provide advice to the DTT Executive Committee and its program director on matters of scientific program content. In addition, he will help to evaluate the scientific merits of the interagency and collaborative programs of the DTT and provide external scientific advice on DTT activities.
Everitt has served on many national and international panels concerning toxicologic pathology, particularly on the effects of inhaled particulates in animal models. He previously served as an ad hoc member of the Science Advisory Committee on Chemicals (SACC) of the U.S. Environmental Protection Agency (EPA). Also, he is associate editor of the journal Toxicologic Pathology, a journal dedicated to the promotion of human, animal, and environmental health through the dissemination of knowledge to enhance the understanding and practice of toxicologic pathology.
In addition, Everitt is a diplomate of the American College of Veterinary Pathologists (ACVP) and a fellow of the International Academy of Toxicologic Pathologists. He is also a member of the Duke Cancer Institute (DCI)
Prior to joining Duke Pathology in 2015, Everitt’s career involved working in toxicologic pathology at the Chemical Industry Institute of Toxicology (CIIT) ̶ a nonprofit research organization that provided scientific data to inform chemical safety regulations and practices. He was also employed by GlaxoSmithKline Pharmaceutical Research and Development.